Skip to main content
CNBX Pharmaceuticals Inc. (CNBX)
OTCMKTS: CNBX · Delayed Price · USD
0.0108
-0.0022 (-16.92%)
Apr 26, 2024, 3:42 PM EDT - Market closed

CNBX Pharmaceuticals Revenue

CNBX Pharmaceuticals had revenue of $540.24K in the twelve months ending February 29, 2024, with 1,703.32% growth year-over-year. Revenue in the quarter ending February 29, 2024 was $40.64K. In the fiscal year ending August 31, 2023, CNBX Pharmaceuticals had annual revenue of $410.17K with 1,269.13% growth.

Revenue (ttm)
$540.24K
Revenue Growth
+1,703.32%
P/S Ratio
0.63
Revenue / Employee
$270,120
Employees
2
Market Cap
342.23K USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Aug 31, 2023410.17K380.21K1,269.13%
Aug 31, 202229.96K--
Aug 31, 20210--
Aug 31, 20207.16K-2.69K-27.29%
Aug 31, 20199.84K242.002.52%
Aug 31, 20189.60K3.92K68.91%
Aug 31, 20175.68K-106.82K-94.95%
Aug 31, 2016112.50K--
Aug 31, 20150--
Aug 31, 20140--
Aug 31, 20130--
Aug 31, 20120--
Aug 31, 20110--
Aug 31, 20100--
Aug 31, 20090--
Aug 31, 20080--
Aug 31, 20070--
Aug 31, 20060--
Aug 31, 20050--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
UnitedHealth Group 371.62B
Johnson & Johnson 85.16B
Merck & Co. 60.12B
AbbVie 54.32B
Novartis AG 49.92B
AstraZeneca 47.61B
Thermo Fisher 42.86B
Abbott Laboratories 40.11B
Revenue Rankings

CNBX News

More News